SBL
LLY icon

Sargent Bickham Lagudis’s Eli Lilly LLY Stock Holding History

Sargent Bickham Lagudis’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$4.23M Buy
11,562
+643
+6% +$228K 0.35% 65
2022
Q3 		$3.53M Buy
10,919
+954
+10% +$302K 0.32% 63
2022
Q2 		$3.23M Sell
9,965
-1,073
-10% -$322K 0.28% 83
2022
Q1 		$3.16M Buy
11,038
+1,268
+13% +$326K 0.25% 84
2021
Q4 		$2.7M Buy
9,770
+8,572
+716% +$2.17M 0.2% 95
2021
Q3 		$277K Buy
1,198
+310
+35% +$76.5K 0.02% 215
2021
Q2 		$204K Buy
888
+125
+16% +$25.1K 0.02% 249
2021
Q1 		$143K Buy
763
+85
+13% +$16.6K 0.01% 288
2020
Q4 		$115K Buy
678
+17
+3% +$2.54K 0.01% 313
2020
Q3 		$98K Hold
661
– – 0.01% 296
2020
Q2 		$109K Hold
661
– – 0.01% 267
2020
Q1 		$92K Sell
661
-219
-25% -$30.1K 0.01% 269
2019
Q4 		$116K Buy
880
+221
+34% +$25.6K 0.01% 265
2019
Q3 		$74K Buy
659
+172
+35% +$19.1K 0.01% 290
2019
Q2 		$54K Buy
487
+1
+0.2% +$118 0.01% 357
2019
Q1 		$63K Sell
486
-126
-21% -$15.3K 0.01% 342
2018
Q4 		$71K Sell
612
-298
-33% -$33.3K 0.01% 316
2018
Q3 		$98K Buy
910
+2
+0.2% +$200 0.01% 279
2018
Q2 		$78K Sell
908
-148
-14% -$12.2K 0.01% 301
2018
Q1 		$82K Sell
1,056
-265
-20% -$21.3K 0.01% 290
2017
Q4 		$112K Buy
1,321
+126
+11% +$10.7K 0.01% 268
2017
Q3 		$102K Buy
1,195
+604
+102% +$49.5K 0.01% 279
2017
Q2 		$49K Buy
591
+65
+12% +$5.3K 0.01% 362
2017
Q1 		$44K Hold
526
– – 0.01% 380
2016
Q4 		$39K Hold
526
– – 0.01% 378
2016
Q3 		$42 Sell
526
-350
-40% -$28K 0.01% 376
2016
Q2 		$69K Hold
876
– – 0.01% 301
2016
Q1 		$63K Buy
+876
New +$66.3K 0.01% 326

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sargent Bickham Lagudis's LLY Position: Q4 2022 in Review

Sargent Bickham Lagudis increased its Eli Lilly (LLY) stake by 5.9% in Q4 2022, buying an estimated $228K and bringing the position to 11,562 shares worth $4.23M. The position accounts for 0.35% of the portfolio, ranked #65.

Sargent Bickham Lagudis first reported a position in LLY in Q1 2016 and has held it in 28 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Sargent Bickham Lagudis held 11,562 shares of Eli Lilly worth $4.23M as of Q4 2022.
  • Sargent Bickham Lagudis bought 643 Eli Lilly shares in Q4 2022, an estimated $228K.
  • Eli Lilly made up 0.35% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #65 holding.
  • Sargent Bickham Lagudis first reported a position in Eli Lilly in Q1 2016 and has held it in 28 quarters since.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.